Condensed Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,030,899	$ 1,885,628
Accounts receivable	4,172	455
Inventory, net	169,655	167,593
Other current assets	304,608	419,521
Total current assets	1,509,334	2,473,197
Intangible assets, net	27,155,594	28,283,208
Property and equipment, net	768,665	876,572
Other assets	320,867	208,827
Total assets	29,754,460	31,841,804
Current liabilities:
Contract liabilities	108,000	112,555
Convertible notes payable	3,000,000
Other notes payable, related party	312,000	42,000
Accrued expenses and others current liabilities	1,285,973	1,182,283
Total current liabilities	4,705,973	1,336,838
Senior secured convertible notes measured at fair value	2,369,694	2,651,556
Convertible notes payable		3,000,000
Other notes payable, related party - noncurrent		270,000
Other long-term liabilities		135,829
Total liabilities	7,075,667	7,394,223
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value; 50,000,000 shares authorized; none issued and outstanding
Common stock, $0.01 par value; 300,000,000 shares authorized as of March 31, 2024 and December 31, 2023, 6,144,506 and 4,677,787 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	61,445	46,778
Common stock to be issued, 270 shares and 162,337 shares as of March 31, 2024 and December 31, 2023, respectively	3	1,623
Additional paid-in capital	64,154,052	62,555,808
Accumulated deficit	(41,200,965)	(37,886,155)
Accumulated other comprehensive loss - translation adjustment	(335,742)	(270,473)
Total stockholders’ equity	22,678,793	24,447,581
Total liabilities and stockholders’ equity	$ 29,754,460	$ 31,841,804